✦ LIBER ✦

Tissue plasminogen activator is elevated in women with ischemic stroke

✍ Scribed by Lise Leth Jeppesen; Henrik Stig Jørgensen; Hirofumi Nakayama; Hans Otto Raaschou; Tom Skyhøj Olsen; Kaj Winther

Book ID: 117707272
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 482 KB
Volume: 7
Category: Article
ISSN: 1532-8511
DOI: 10.1016/s1052-3057(98)80005-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intravenous Tissue Plasminogen Activator

Intravenous Tissue Plasminogen Activator for Patients with Minor Ischemic Stroke

✍ Huisa, Branko N.; Raman, Rema; Neil, Will; Ernstrom, Karin; Hemmen, Thomas M. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Local tissue-type plasminogen activator

Local tissue-type plasminogen activator release in patients with ischemic stroke

✍ K. JOOD; C. JERN; C. BLOMSTRAND; S. JERN; T. HRAFNKELSDÓTTIR 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

Tissue plasminogen activator for acute i

Tissue plasminogen activator for acute ischemic stroke in patients with unruptured cerebral aneurysms

✍ Luis D'Olhaberriague; Nishit Joshi; Seement Chaturvedi; Panayiotis Mitsias; Will 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Tissue plasminogen activator use in a pa

Tissue plasminogen activator use in a patient with acute ischemic stroke coexisting with meningioma

✍ Han-Chieh Hsieh; Chih-Hung Chen 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 195 KB

Intravenous tissue plasminogen activator

Intravenous tissue plasminogen activator treatment for ischemic stroke in dabigatran-treated patients

✍ Satoru Takeuchi; Kojiro Wada; Kimihiro Nagatani; Naoki Otani; Hideo Osada; Hiros 📂 Article 📅 2011 🏛 Springer Vienna 🌐 English ⚖ 45 KB

Medico-Legal Aspects of Using Tissue Pla

Medico-Legal Aspects of Using Tissue Plasminogen Activator in Acute Ischemic Stroke

✍ Nhu T. Bruce; William P. Neil; Justin A. Zivin 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 109 KB

## Opinion statement Intravenous alteplase or tissue plasminogen activator (tPA) has been the standard of care with proven efficacy for acute ischemic stroke for over a decade. Despite this, only a small fraction of potentially eligible stroke patients receive this medication. There seems to be a f